<PAGE> 1
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
---------------------
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): JUNE 30, 1997
D & K WHOLESALE DRUG, INC.
(Exact name of registrant as specified in its charter)
DELAWARE 0-20348 43-1464583
(State or other (Commission File (I.R.S. Employer
jurisdiction of Number) Identification
organization) Number)
8000 MARYLAND AVENUE
SUITE 1190
ST. LOUIS, MISSOURI 63105
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (314) 727-3485
Page 1 of 3 pages
No Exhibit Index
<PAGE> 2
ITEM 8. CHANGE IN FISCAL YEAR.
On June 30, 1997, D & K Wholesale Drug, Inc., a Delaware corporation
("the Company"), determined that it would change from a fiscal year ending on
the Friday closest to March 31 in each year to a fiscal year ending June 30 of
each year. The Company intends to file a report on Form 10-Q for the three
month transition report ending June 30, 1997, and will begin its first full
fiscal year on the new basis on July 1, 1997.
- 2 -
<PAGE> 3
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of
1934, the Registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
Dated: June 30, 1997
D & K WHOLESALE DRUG, INC.
By /s/ Daniel E. Kreher
--------------------------------------
Daniel E. Kreher, Vice President--
Finance and Administration
- 3 -
